Security key
501575104
CUSIP: 501575104
Security key
501575104
Report period
Q1 2022
Institutions
124
Top holders
10
Broader feeds
Reporting periods
Recent filing periods:
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Rank 1 holder
Rank 2 holder
Rank 3 holder
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC |
13F
Company
|
8.4%
|
$436,538,000
6,875,698 shares
|
— | 31 Dec 2021 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
4.4%
|
$225,423,000
3,550,528 shares
|
— | 31 Dec 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
4.2%
|
$215,709,000
3,397,540 shares
|
— | 31 Dec 2021 |
| BVF INC/IL |
13F
Company
|
3.9%
|
$201,940,000
3,180,658 shares
|
— | 31 Dec 2021 |
| VANGUARD GROUP INC |
13F
Company
|
3.6%
|
$187,751,000
2,957,174 shares
|
— | 31 Dec 2021 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
3.3%
|
$171,093,000
2,694,814 shares
|
— | 31 Dec 2021 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Investor-level positions for this CUSIP, loaded as an interactive table.
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).